Hybrid reverse transcriptases
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Dec 10, 2024
Grant Date -
Jan 21, 2021
app pub date -
Jul 14, 2020
filing date -
Jul 14, 2020
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Hybrid reverse transcriptases are provided that comprise a non-retroviral retrotransposon, or a fragment of the non-retroviral retrotransposon having reverse transcriptase activity, joined to a nucleic acid binding protein. Also provided are methods of using the hybrid reverse transcriptases to prepare a cDNA molecule library.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2020 Application Filing Year
- C12R Class
- 138 Applications Filed
- 38 Patents Issued To-Date
- 27.54 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12R Class
- 0 % this patent is cited more than
- 1 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jun 10, 2028 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jun 10, 2032 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 10, 2036 |